Совместимость Энап® Р и Эральфон®
Страница описания препарата Энап® Р
Страница описания препарата Эральфон®
Cтепень серьёзности/тяжести
Достоверность
Описание взаимодействия
Источники
Печатные издания
Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers
Br J Clin Pharmacol /Volume:34 Part:4/Oct Page:363-5 / 1992 / Pratt MC, Lewis-Barned NJ, Walker RJ et al
High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients
Nephrol Dial Transplant /Volume:13 Part:5/May Page:1206-10 / 1998 / Albitar S, Genin R, Fen-Chong M et al
Potential angiotensin-converting enzyme inhibitor–epoetin alfa interaction in patients receiving chronic hemodialysis
Pharmacotherapy /Volume:18 Part:3/May-Jun Page:627–30 / 1998 / Schwenk MH, Jumani AQ, Rosenberg CR et al
Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?
Nephrol Dial Transplant /Volume:11 Part:4/Apr Page:749-51 / 1996 / Hess E, Sperschneider H, Stein G
Ace inhibitors and erythropoietin responsiveness
Am J Kidney Dis /Volume:38 Part:3/Sep Page:649-51 / 2001 / Macdougall IC
The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients
Nephrol Dial Transplant /Volume:14 Part:8/Aug Page:1912-6 / 1999 / Ertürk S, Nergizoğlu G, Ateş K et al